Ameritas Investment Company’s State Street SPDR S&P 600 Small Cap Value ETF SLYV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$921K Buy
11,242
+3,011
+37% +$247K 0.04% 287
2021
Q2
$774K Buy
8,231
+4,487
+120% +$382K 0.04% 331
2021
Q1
$307K Sell
3,744
-4,253
-53% -$328K 0.03% 457
2020
Q4
$525K Buy
7,997
+492
+7% +$29.2K 0.1% 213
2020
Q3
$369K Hold
7,505
0.12% 200
2020
Q2
$369K Sell
7,505
-1,921
-20% -$88K 0.11% 206
2020
Q1
$384K Buy
9,426
+373
+4% +$21.1K 0.06% 227
2019
Q4
$595K Buy
9,053
+2,353
+35% +$149K 0.12% 158
2019
Q3
$410K Buy
6,700
+2,888
+76% +$173K 0.08% 215
2019
Q2
$231K Sell
3,812
-3,946
-51% -$239K 0.11% 193
2019
Q1
$468K Sell
7,758
-2,696
-26% -$163K 0.09% 182
2018
Q4
$563K Buy
+10,454
New +$634K 0.12% 150

Other funds holding SLYV

Ameritas Investment Company's SLYV Position: Q3 2021 in Review

Ameritas Investment Company increased its State Street SPDR S&P 600 Small Cap Value ETF (SLYV) stake by 37% in Q3 2021, buying an estimated $247K and bringing the position to 11,242 shares worth $921K. The position accounts for 0.04% of the portfolio, ranked #287.

Ameritas Investment Company first reported a position in SLYV in Q4 2018 and has held it in 12 quarters since. 390 funds tracked by Wall St. Rank hold SLYV as of Q3 2021.

  • Ameritas Investment Company held 11,242 shares of State Street SPDR S&P 600 Small Cap Value ETF worth $921K as of Q3 2021.
  • Ameritas Investment Company bought 3,011 State Street SPDR S&P 600 Small Cap Value ETF shares in Q3 2021, an estimated $247K.
  • State Street SPDR S&P 600 Small Cap Value ETF made up 0.04% of Ameritas Investment Company's portfolio in Q3 2021, its #287 holding.
  • Ameritas Investment Company first reported a position in State Street SPDR S&P 600 Small Cap Value ETF in Q4 2018 and has held it in 12 quarters since.
  • 390 funds tracked by Wall St. Rank held State Street SPDR S&P 600 Small Cap Value ETF as of Q3 2021.

Based on Ameritas Investment Company's 13F filing for Q3 2021, filed 12 Nov 2021.